NEW YORK, Oct. 5, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Asia Pacific Pharmaceutical Market: Strategic Assessments of Leading Suppliers
This report provides industry executives with strategically significant competitor information and analysis of the leading players in the Asia Pacific pharmaceutical market.
The report provides a worldwide strategic overview of the pharmaceutical market, including:
• Sales forecast for major product segments: ethical, OTC, generics.
• Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others.
In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies.
The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
<Page: 1 2 3 4 5 6 7 Related medicine technology :1
. Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial2
. Rapid Growth of Asia-Pacific Clinical Trials Market Focus of New CenterWatch Report3
. PacificGMP Completes GMP Product Fill for Trius Therapeutics4
. Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study5
. Pharmacyclics, Inc. Announces Closing of a Private Financing With the Principals of Pacific Biopharma Group, Ltd.6
. Health Robotics Reaches 100% Asia-Pacific Coverage Through its New Exclusive Distribution Contract With BioRobotics in Korea7
. WuXi PharmaTech Included in the Deloitte Technology Fast 500 Asia Pacific 2009 List for the Sixth Consecutive Year8
. PAREXEL Expert To Lead Panel on Innovative Drug Development in Asia at Partnerships in Clinical Trials Asia Pacific Conference9
. American Pacific to Release Financial Results and Hold Fiscal 2010 Second Quarter Investor Teleconference10
. Swedish Cancer Institute and Elekta Launch Renewed Partnership Agreement to Continue the Flow of World-Class Technology, Services to Cancer Patients in the Pacific Northwest and Beyond11
. Pacific Bridge Medical to Host Taiwan Drug Registration Webinar